HOMEVULNERABILITIESCVE-2023-22377
HIGH

CVE-2023-22377

CWE-611Published: February 15, 2023· Updated: Jun 17, 2026

7.4
CVSS v3.1

Official Description

Improper restriction of XML external entity reference (XXE) vulnerability exists in tsClinical Define.xml Generator all versions (v1.0.0 to v1.4.0) and tsClinical Metadata Desktop Tools Version 1.0.3 to Version 1.1.0. If this vulnerability is exploited, an attacker may obtain an arbitrary file which meets a certain condition by reading a specially crafted XML file.

NVD Source

Technical Analysis

CVE-2023-22377 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), with a CVSS base score of 7.4.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityNone
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

Affected Vendors & Products

fujitsu2 product(s)
tsclinical define.xml generatortsclinical metadata desktop tools
Source: NVD CPE · 2 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

ADVISORYhttps://github.com/tsClinical/tsc-desktop/security/advisories
ADVISORYhttps://jvn.jp/en/jp/JVN00712821/
ADVISORYhttps://github.com/tsClinical/tsc-desktop/security/advisories
ADVISORYhttps://jvn.jp/en/jp/JVN00712821/

All References (4)

→
https://github.com/tsClinical/tsc-desktop/security/advisoriesThird Party Advisory
→
https://jvn.jp/en/jp/JVN00712821/Third Party Advisory
→
https://github.com/tsClinical/tsc-desktop/security/advisoriesThird Party Advisory
→
https://jvn.jp/en/jp/JVN00712821/Third Party Advisory

Quick Facts

CVE IDCVE-2023-22377
CVSS Score7.4 / 10
SeverityHIGH
WeaknessCWE-611
CISA KEVNo
Affected1 vendor(s)
PublishedFeb 15, 2023

Related CVEs (CWE-611)

CVE-2018-1000822
10.0
CVE-2018-1000825
10.0
CVE-2018-1000820
10.0
CVE-2018-1000821
10.0
CVE-2018-1000823
10.0
CVE-2018-1000835
10.0

Recommended Actions

  • →Apply vendor patches immediately
  • →Monitor CVE-2023-22377 in threat intel feeds
  • →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.
← All Vulnerabilities·Search for CVE-2023-22377·NVD